EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small molecule inhibitors of hnRNPA2B1–RNA interactions reveal a predictable sorting of RNA subsets into extracellular vesicles

Jessica Corsi, Pouriya Sharbatian Semnani, Daniele Peroni, Romina Belli, Alessia Morelli, Michelangelo Lassandro, Viktoryia Sidarovich, Valentina Adami, Chiara Valentini, Paolo Cavallerio, Julian Grosskreutz, Fabrizio Fabbiano und 5 weitere

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Jessica Corsi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommar…. Hauptthemen laut MEDLINE: Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Extracellular Vesicles, RNA, Small Molecule Libraries. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Fondazione Cassa di Risparmio Trento e Rovereto, Caritro, Italian Ministry of University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are cell-secreted membranous particles contributing to intercellular communication. Coding and noncoding RNAs can be detected as EV cargo, and RNA-binding proteins (RBPs), such as hnRNPA2B1, have been circumstantially implicated in EV-RNA sorting mechanisms. However, the contribution of competitive RBP–RNA interactions responsible for RNA-sorting outcomes is still unclear, especially for predicting the EV-RNA content. We designed a reverse proteomic analysis exploiting the EV-RNA to identify intracellular protein binders in vitro. Using cells expressing a recombinant hnRNPA2B1 to normalize competitive interactions, we prioritized a network of heterogeneous nuclear ribonucleoproteins and purine-rich RNA sequences subsequently validated in secreted EV-RNA through short fluorescent RNA oligos. Then, we designed a GGGAG-enriched RNA probe that efficiently interacted with a full-length human hnRNPA2B1 protein. We exploited the interaction to conduct a pharmacological screening and identify inhibitors of the protein–RNA binding. Small molecules were orthogonally validated through biochemical and cell-based approaches. Selected drugs remarkably impacted secreted EV-RNAs and reduced an RNA-dependent, EV-mediated paracrine activation of NF-kB in recipient cells. These results demonstrate the relevance of post-transcriptional mechanisms for EV-RNA sorting and the possibility of predicting the EV-RNA quality for developing innovative strategies targeting discrete paracrine functions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heterogeneous-Nuclear Ribonucleoprotein Group A-BExtracellular VesiclesRNASmall Molecule LibrariesHumansProtein BindingHEK293 CellsRNA-Binding ProteinsProteomicsNF-kappa B

Substanzen

Heterogeneous-Nuclear Ribonucleoprotein Group A-BRNASmall Molecule LibrariesRNA-Binding ProteinshnRNP A2NF-kappa B

Autor:innen und Institutionen

  • Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommarive 9, 38123 Trento, Italy.
  • MS Core Facility, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommarive 9, 38123 Trento, Italy.
  • HTS Core Facility, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommarive 9, 38123 Trento, Italy.
  • NGS Core Facility, Department of Cellular, Computational and Integrative Biomedicine CIBIO, University of Trento, 38122 Trento, Italy.
  • Excellence Cluster Precision Medicine in Inflammation, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
  • Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.

ORCID-Profile: Andreas Hermann, Gianluca Tell, Manuela Basso, Vito G D'Agostino

Förderung

  • Italian Ministry of Health
  • Fondazione Cassa di Risparmio Trento e Rovereto, Caritro
  • Italian Ministry of University and Research
  • Deutschen Gesellschaft für Parkinson und Bewegungsstörungen
  • DFG
  • Hermann und Lilly Schilling-Stiftung für medizinische Forschung
  • European Regional Development Fund
  • European Union - Next Generation EU

Zitieren

APA

Corsi, J., Semnani, P. S., Peroni, D., Belli, R., Morelli, A., Lassandro, M., Sidarovich, V., Adami, V., Valentini, C., Cavallerio, P., Grosskreutz, J., Fabbiano, F., Grossmann, D., Hermann, A., Tell, G., Basso, M., & D'Agostino, V. G. (2025). Small molecule inhibitors of hnRNPA2B1–RNA interactions reveal a predictable sorting of RNA subsets into extracellular vesicles. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf176

Vancouver

Corsi J, Semnani PS, Peroni D, Belli R, Morelli A, Lassandro M, et al. Small molecule inhibitors of hnRNPA2B1–RNA interactions reveal a predictable sorting of RNA subsets into extracellular vesicles. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf176

BibTeX
@article{Corsi2025,
  author = {Corsi, Jessica and Semnani, Pouriya Sharbatian and Peroni, Daniele and Belli, Romina and Morelli, Alessia and Lassandro, Michelangelo and Sidarovich, Viktoryia and Adami, Valentina and Valentini, Chiara and Cavallerio, Paolo and Grosskreutz, Julian and Fabbiano, Fabrizio and Grossmann, Dajana and Hermann, Andreas and Tell, Gianluca and Basso, Manuela and D'Agostino, Vito G},
  title = {Small molecule inhibitors of hnRNPA2B1–RNA interactions reveal a predictable sorting of RNA subsets into extracellular vesicles},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf176}
}
Kostenlos starten →